Skip to content

iRadimed IRMD Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

ICU Medical logo
ICU MedicalICUI
ITG
Integer HoldingsITGR
RadNet logo
RadNetRDNT
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
PROCEPT BioRobotics Corporation logo
PROCEPT BioRobotics CorporationPRCT
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
Operating cash flow$8.3M+93.2%
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.21B+63.4%
P/E51.3×+13.8×
P/S14×+4.2×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp
FCF margin28.4%+8.9pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0.0×
Current ratio7.1×-1.7×

Where this comes from

Reported directly by iRadimed in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's common stock, shares authorized (in shares)?
iRadimed (IRMD) reported common stock, shares authorized (in shares) of $31.5M in Q1 2026.